The Rapid Response Unit (RRU) of the ODPRN was created with the goal of rapidly conducting policy-relevant research in Ontario, and communicates regularly with key policy-makers in the Ontario government to determine areas of high priority for drug research. The RRU is comprised of two teams: the Pharmacoepidemiology Program and the Project Management Team.
The RRU houses the Pharmacoepidemiology Program, which rapidly responds to research requests from the ministry of health and long-term care using the administrative claims databases housed at the Institute for Clinical Evaluative Sciences (ICES). These linked databases include information on physician claims, hospitalizations, emergency department visits, geographic location, vital statistics on the entire population of Ontario, and drug utilization data on the elderly population and those receiving social assistance. The pharmacoepidemiology program:
- Explores novel methodologies in observational research,
- Conducts clinically relevant comparative effectiveness and drug safety research driven by members of the Core Academic Unit, and
- Refines the study design and data extraction processes to allow for increasingly rapid turnaround of research requests.
Comprised of a team of experienced epidemiologists, biostatisticians, analysts, project managers and clinicians, the pharmacoepidemiology program collaboratively and quickly responds to the needs of drug policy-makers in Ontario. Additionally, cross-provincial differences in policy decisions are facilitated through collaborations with members of the Core Academic Unit, Canadian Drug Safety and Effectiveness Research Network (CDSERN), the Canadian Institute for Health Information’s National Prescription Drug Utilization Information System (NPDUIS), and IQVIA
Project Management Team
A Project Management Team comprised of dedicated project managers and research administrators organizes, coordinates, and facilitates the work of the RRU as well as the other units of the ODPRN. The RRU serves as the hub of many of the ODPRN’s activities by acting as the central team responding to policy-maker requests.
Tara Gomes – Scientific Lead
Tara Gomes is an epidemiologist, a Principal Investigator of the Ontario Drug Policy Research Network and a Scientist at St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences. She is also an assistant professor at the University of Toronto and holds a Canada Research Chair in Drug Policy Research and Evaluation. Her research program focuses on pharmacoepidemiology, drug safety and drug policy research, with a specific interest in developing evidence to inform policies related to the safety of opioid use across Canada
Mina Tadrous – Research Associate
Dr. Mina Tadrous is a scientist at Women’s College Hospital Institute for Health System Solutions and Virtual Care. He is also an investigator with the Ontario Drug Policy Research Network (ODPRN) and an ICES adjunct scientist. Mina’s research interests lie in drug policy research and the post-marketing surveillance of safety and effectiveness of medications used to treat chronic diseases. He completed a PhD in pharmacoepidemiology at the University of Toronto, a Masters in Health Outcomes and Policy Research at the University of Tennessee, a Doctor of Pharmacy at Albany College of Pharmacy, and a pharmacy residency in Drug Information and Health Outcomes at the University of Tennessee and St. Jude Children’s Research Hospital. He is a practicing pharmacist who has worked in a variety of clinical settings.
Tony Antoniou – Research Associate
Tony Antoniou is a scientist at St. Michael’s Hospital and ICES, as well as an associate professor at the University of Toronto. His areas of research include drug safety, drug interactions at the population level, and drug policy evaluation
Diana Martins – Research Program Manager
Diana holds a Master of Science (MSc) in Epidemiology with Specialization in Biostatistics degree from Queen’s University, and previous to this completed an Honours Bachelor of Science (BScH) in Life Sciences and Mathematics and Statistics from Queen’s University. Diana’s areas of research includes real-world drug utilization, adherence and appropriateness of drug use as well as assessing the impact of policy interventions on utilization, cost and health outcomes.
Samantha Singh – Project Manager
Samantha is a Senior Research Project Manager with the with the Ontario Drug Policy Research Network based at the Li Ka Shing Knowledge Institute at St. Michael’s Hospital. She received her Bachelor of Science through York University. She is responsible for managing the ODPRN research portfolio.
Tonya Campbell – Epidemiologist
Tonya is an epidemiologist with the ODPRN and is based at the Institute for Clinical Evaluative Sciences. She holds a Master of Public Health (MPH) in Epidemiology from the Dalla Lana School of Public Health and a Honours Bachelor of Science in Biology and Health Studies from the University of Toronto. Tonya’s research interests include using administrative and survey data to address the challenges affecting the health and well-being of Canadians.
Sophie Kitchen – Epidemiologist
Sophie is an epidemiologist with the ODPRN based at the Li Ka Shing Knowledge Institute at St. Michael’s Hospital. She holds a Master of Science from the School of Population and Public Health at the University of British Columbia and a Bachelor’s degree in Chemistry from Williams College. Sophie’s research interests include examining the impact of policy interventions on prescription drug and health services utilization.
Daniel McCormack – Research Analyst
Daniel is a research analyst with the ODPRN and is based out of the Institute for Clinical Evaluative Sciences. He received his Master of Science in Epidemiology from the University of Ottawa and previously completed a Bachelor of Science in Biochemistry at McGill University.
Siyu Men – Research Analyst
Siyu is a research analyst with ODPRN and is based at the Institute for Clinical Evaluative Sciences. She holds a Master of Science in Biostatistics from the Dalla Lana School of Public Health from the University of Toronto.